US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
USOTC
Luckwel Pharmaceuticals Inc (GM) (LWEL)
Luckwel Pharmaceuticals Inc (GM) (LWEL) ニュース

LWEL

Luckwel Pharmaceuticals (GM) (LWEL)

Luckwel Pharmaceuticals Inc (GM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:LWEL

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/10/02	00 : 37	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/09/23	06 : 07	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/09/21	19 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/09/08	21 : 31	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/06/11	06 : 21	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/05/26	23 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/04/27	20 : 48	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/03/22	19 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/02/06	04 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/01/13	22 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2021/01/05	01 : 15	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2020/02/14	05 : 23	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2019/11/15	04 : 16	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2019/08/15	05 : 39	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2019/07/04	02 : 02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2019/07/02	19 : 02	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2019/06/13	06 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2019/03/15	06 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2019/02/15	01 : 29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/11/15	02 : 49	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/10/12	00 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/08/15	06 : 06	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/07/16	19 : 31	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/06/30	01 : 47	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/06/21	01 : 51	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/05/08	02 : 57	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/03/20	00 : 40	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/03/07	01 : 41	Edgar (US Regulatory)	Proxy Statement - Other Information (preliminary) (pre 14c)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2018/02/12	21 : 03	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)
2017/12/19	01 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LWEL	Luckwel Pharmaceuticals Inc (GM)

Showing the most relevant articles for your search:USOTC:LWEL

NLBNPIT1ZJQ5 20240918 5200

NLBNPIT1Z8H0 20240620 5200

NLBNPIT1Y375 20240621 7.5

Radient Technologies

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約